ADAR1 Capital Management LLC 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 8:16 pm Purchase | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | ADAR1 Capital Management LLC | 102,883 4.900% | 44,653 (+76.68%) | Filing |
| 2026-02-17 8:14 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | ADAR1 Capital Management LLC | 58,230 6.900% | 58,230 (New Position) | Filing |